Skip to content [s] Site map [3] Home [1]
Graphic text

Cancer Research and Foundation News

Cancer Research: It's About Time

March 16, 2012

Effective treatment of chronic myeloid leukemia (CML) occurred only after four decades of dedicated research. New drugs targeting the BCR-Abl protein transformed CML from a lethal diagnosis to a manageable disease for more than 90% of patients. Click article title to read the full story.

Antidepressant Shows Promise as Cancer Treatment

March 12, 2012

An antidepressant combined with a drug derived from vitamin A could be used to treat a common adult form of leukemia. A retinoid called all-trans retinoic acid (ATRA), which is a vitamin A-derivative, is already used successfully to treat a rare sub-type of acute myeloid leukemia (AML), however this drug has not been effective for the more common types of AMLs. Until now, it’s been a mystery why the other forms of AML don’t respond to this drug. This study revealed that there was a molecular block that could be reversed with a second drug that is already commonly used as an antidepressant.

Childhood Leukemia Survival Rates Reach 90 Percent

March 12, 2012

Children with acute lymphoblastic leukemia (ALL, the most common type) now have a dramatically better chance of survival, a new study shows.

Share this Page

Stay Connected

Button Button Button Button

Get Hope!

Sign up for our newsletter and updates.

CHRISTUS Stehlin Foundation for Cancer Research

10301 Stella Link Road, Suite A
Houston, Texas 77025-5447

Affiliates and Resources

Logo Logo Logo Logo Logo